Filter
1778
Filtered Results: 1778
Text search:
molecular
Featured
Recommendations
205
New Publications
331
Language
Document type
No document type
780
Guidelines
394
Studies & Reports
317
Manuals
103
Strategic & Response Plan
76
Fact sheets
53
Training Material
19
Situation Updates
17
Resource Platforms
9
Infographics
7
Videos
2
Brochures
1
Countries / Regions
India
95
Latin America and the Carribbean
70
Global
62
Brazil
61
Western and Central Europe
60
Africa
39
Eastern Europe
36
Germany
34
Kenya
30
Colombia
30
South Africa
28
Ethiopia
22
Tanzania
22
Peru
22
Argentina
20
West and Central Africa
20
Venezuela
20
Russia
18
East and Southern Africa
17
El Salvador
16
Paraguay
15
Uganda
14
Mozambique
14
South–East Asia Region
14
Sierra Leone
13
Bolivia
13
Nigeria
12
Malawi
12
Senegal
11
Philippines
11
Rwanda
11
Nepal
10
Angola
10
Asia
10
Congo, Democratic Republic of
9
Zambia
9
Ukraine
9
Ecuador
9
Chile
9
Liberia
8
Indonesia
8
Middle East and North Africa
8
Ghana
7
Bangladesh
7
Namibia
7
Spain
7
Zimbabwe
6
Syria
6
Myanmar / Burma
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
Guinea-Bissau
4
USA
4
Cameroon
4
Haiti
4
Pakistan
4
Italy
4
Vietnam
4
France
4
Guinea
3
Burkina Faso
3
Lebanon
3
Cambodia
3
Benin
3
Eswatini/ Swaziland
3
Botswana
3
Uruguay
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Niger
2
Somalia
2
South Sudan
2
Iraq
2
Jordan
2
Turkey
2
Chad
2
Thailand
2
China
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Tajikistan
2
Georgia
2
North America
2
United Kingdom
2
Portugal
2
Morocco
1
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
North Macedonia
1
Switzerland
1
Cuba
1
Madagascar
1
Lesotho
1
Mexico
1
Nicaragua
1
Yemen
1
Palestine
1
Congo-Brazzaville
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
615
Clinical Guidelines
223
Public Health
76
Pharmacy & Technologies
65
Key Resources
29
Women & Child Health
23
Capacity Building
6
Toolboxes
TB
389
COVID-19
279
AMR
113
NTDs
111
HIV
86
Rapid Response
78
Mental Health
78
Ebola
46
Planetary Health
46
Zika
33
Pharmacy
31
NCDs
27
Refugee
21
Polio
14
Caregiver
14
Specific Hazards
11
Cholera
10
Global Health Education
9
Disability
8
Health Financing Toolbox
6
Conflict
5
Natural Hazards
4
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe...
This document provides additional guidance for the responsible and prudent use of antimicrobials in food-producing animals, and should be read in conjunction with the Recommended International Code of Practice for Control of the Use of Veterinary Drugs CAC/RCP 38-1993. Its obj...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...
Handbook of COVID-19 Prevention and Treatment
recommended
Handbook of COVID-19 Prevention and Treatment, expecting to share their invaluable practical advice and references with medical staff around the world. This handbook compared and analyzed the experience of other experts in China, and provides good reference to key departments such as hospital infect...
Em 22 de janeiro de 2020, foi ativado o Centro de Operações de Emergências em Saúde Pública para o novo Coronavírus (COE – nCoV), estratégia prevista no Plano Nacional de Resposta às Emergências em Saúde Pública do Ministério da Saúde.
O novo Coronavírus (2019-nCoV) é um vírus ide...
The animal health subsector within the agriculture sector is the gatekeeper of antimicrobial resistance (AMR) in livestock, aquaculture, animal products, and the immediate animal environment. In support of member countries taking responsibility for and moving forward with putting AMR monitoring and ...
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of antibacterial agents in order ...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
COVID-19: Guidelines for case-finding, diagnosis, management and public health response in South Africa
recommended
The information contained in this document, be it guidelines, recommendations, diagnostic algorithms or treatment regimens, are offered in this document in the public interest. To the best of the knowledge of the guideline writing team, the information contained in these guidelines is correct. Imple...
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Intensive Care Med (2009) 35:9–29DOI 10.1007/s00134-008-1336-9
Although thousands of papers have been devoted tohospital-acquired pneumonia (HAP), many controversiesremain, and management of HAP is probably often sub-optimal. Several reviews or guidelines have been pub-lished rec...
The guidelines are to be used to guide the management of adults with lower respiratory tract infection (LRTI). As will be seen in the following text, this diagnosis, and the other clinical syndromes within this grouping, can be difficult to make accurately. In the absence of agreed definitions of th...
The international community sits at the tipping pointof a post-‐antibiotic era, where common bacterial infections are no longer treatable with the antibiotic armamentarium that exists. In South Africa, t...
This interim guidance is for LTCF managers and corresponding infection prevention and control (IPC) focal persons in LTCF and updates the guidance published in March 2020. The objective of this document is to provide guidance on IPC in LTCFs in the context of COVID-19 to 1) prevent COVID-19-virus fr...
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
Stenotrophomonas maltophiliais a nonfermenting Gram-negative rod that is ubiquitous in nature (predominantly occurring in aquatic environments and on plants). Biochemically, it iscatalase positive and oxidase negative, and it produces acid frommaltose (hence the name“maltophilia”). Due to it...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
